Products - Cystic fibrosis | Topic | NICE

Showing 4 products

Date | Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
Status: PublishedRemove ‘Status: Published’ filter

Ivacaftor–tezacaftor–elexacaftor, tezacaftor–ivacaftor and lumacaftor–ivacaftor for treating cystic fibrosis (TA988)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
24 July 2024
Cystic fibrosis: diagnosis and management (NG78)
Product type:
Guidance
Programme:
NICE guideline
Published:
25 October 2017
Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis (TA276)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
27 March 2013
Mannitol dry powder for inhalation for treating cystic fibrosis (TA266)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
28 November 2012